e-learning
resources
London 2016
Wednesday, 07.09.2016
Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacologic treatment of exacerbations of COPD
Antonio R. Anzueto (San Antonio, United States of America)
Source:
International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Session:
Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Session type:
Symposium
Number:
4948
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Antonio R. Anzueto (San Antonio, United States of America). Pharmacologic treatment of exacerbations of COPD. International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Non-pharmacological treatment in asthma and COPD
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019
Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Corticosteroids and exacerbations of COPD
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
N-acetylcysteine for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010
Macrolides in the prevention of COPD exacerbations
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Impact of halotherapy on COPD exacerbations
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
Acute management of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept